Cytel is a startup based in the United States, most recent round Series-c-plus, 2 tracked investors.
Cytel is a startup founded in 1987 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Cytel is a multinational statistical software developer and contract research organization providing clinical trial design and implementation services and statistical software products primarily for the biotech and pharmaceutical development markets. It specializes in adaptive trials, a type of randomized clinical trial that allows modifications of ongoing trials while aiming to preserve statistical validity and integrity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.